-
American Express November Write-Off Rate At 4.4% (AXP)
Wednesday, December 15, 2010 - 12:41pm | 32American Express (NYSE: AXP) reports November U.S. Managed Net write-off rate was 4.4% vs 4.7% in October. November loans 30 days past-due were 2.2% vs 2.3% in October.
-
J.P. Morgan's Thoughts on Discover Financial
Tuesday, December 14, 2010 - 11:02am | 126J.P. Morgan published its report today on Discover Financial Services (NYSE: DFS) in anticipation of Thursday's earnings. In a note to clients, "YTD, DFS has significantly outperformed the peer group, appreciating 31.0% compared to the group average of 18.4% and the SPX return of 11.2%. The company...
-
KBW's 2011 Student Lenders Outlook
Tuesday, December 14, 2010 - 10:29am | 181KBW released its 2011 Specialty Finance Student Lenders Outlook with price target risks listed for the following companies: Asset Acceptance Capital Corporation (NASDAQ: AACC) Target Price: $6.00 Risk Factors: Risks to our price target include substantially greater-than-estimated impairment charges...
-
EGI Acquisition Completes Tender Offer to Acquire Shares of Rewards Network
Tuesday, December 14, 2010 - 10:27am | 98Equity Group Investments, L.L.C. announced today that EGI Acquisition, L.L.C. has successfully completed its tender offer to acquire all of the shares of Rewards Network Inc. (NASDAQ: DINE) common stock not owned by EGI Acquisition. Based upon information provided by American Stock Transfer &...
-
MITI Presents Positive Data at ASH - Analyst Blog
Monday, December 13, 2010 - 5:33pm | 609Recently, biopharmaceutical company, Micromet Inc. (MITI) presented updated durability data from a phase II study of its blood cancer pipeline drug blinatumomab (MT103) at the annual meeting of the American Society of Hematology (ASH). The phase II study was evaluating the safety and efficacy...
-
MITI Presents Positive Data at ASH - Analyst Blog
Monday, December 13, 2010 - 5:00pm | 609Recently, biopharmaceutical company, Micromet Inc. (MITI) presented updated durability data from a phase II study of its blood cancer pipeline drug blinatumomab (MT103) at the annual meeting of the American Society of Hematology (ASH). The phase II study was evaluating the safety and efficacy...
-
Keefe Bruyette & Woods On Credit Cards
Monday, December 13, 2010 - 9:31am | 110Keefe Bruyette & Woods writes "American Express, Capital One, Discover Financial, and Alliance Data Systems are expected to report November monthly data on Wednesday (12/15). In this note, we provide a recap of previous data, seasonal trends seen in November, our current estimates for the...
-
Heavy Data Week Ahead - Earnings Preview
Friday, December 10, 2010 - 6:33pm | 4894Earnings Preview 12/10/10 The third quarter earnings season is over, and we will actually start to see a handful of fourth quarter reports next week, those with November fiscal ends. Only 63 firms will report, but 6 of those will be S&P 500 firms. We define any fiscal period ending in November...
-
VeriFone Key Player in Mobile Payment Revolution
Friday, December 10, 2010 - 4:56pm | 705VeriFone Systems Inc. (NYSE: PAY) is one of the key players in a growing movement to replace credit cards with smartphone payment applications. As a result, the San Jose company has seen its stock nearly triple in the past year. VeriFone is among the top five holdings of my Silicon Valley 2.0...
-
Company News For Dec 10, 2010 - Corporate Summary
Friday, December 10, 2010 - 10:33am | 589• China's Petrochemical agreed to purchase Occidental Petroleum's (NYSE: OXY) oil and gas holding in Argentina for $2.45 billion • Community Health (NYSE: CYH) made an offer for Tenet (NYSE: THC) for $3.3 billion, or $6 per share, which the firm declined • Beckman Coulter (NYSE: BEC) is examining...
-
Company News For Dec 10, 2010 - Corporate Summary
Friday, December 10, 2010 - 10:15am | 589• China's Petrochemical agreed to purchase Occidental Petroleum's (NYSE: OXY) oil and gas holding in Argentina for $2.45 billion • Community Health (NYSE: CYH) made an offer for Tenet (NYSE: THC) for $3.3 billion, or $6 per share, which the firm declined • Beckman Coulter (NYSE: BEC) is examining...
-
Capital One Upgraded to Outperform at FBR Capital
Friday, December 10, 2010 - 9:14am | 27Capital One (NYSE: COF) is upgraded from Market Perform to Outperform at FBR Capital, price target raised from $45 to $53.
-
Deutsche Bank Reiterates Buy on Cardtronics
Friday, December 10, 2010 - 8:50am | 101Deutsche Bank reiterates its Buy rating on Cardtronics (NASDAQ: CATM). In a note to clients, Deutsche Bank writes, "The CATM growth story is straightforward in our view: adding new ATMs to the network and adding new fee streams to existing ATMs within the network. We believe the latter is far more...
-
Deutsche Bank Raises PT On Cardtronics
Friday, December 10, 2010 - 8:18am | 22Deutsche Bank has raised the price target on Cardtronics, Inc. (NASDAQ: CATM) from $21 to $25.
-
Mad Money Lightning Round: Cramer Advises Investors To Buy BlackRock (LLY, DECK, CMI, OXPS, AXP, V, MRK, ABT, BLK)
Friday, December 10, 2010 - 4:21am | 265On CNBC's Mad Money, Jim Cramer said during the Lightning Round that Eli Lilly (NYSE: LLY) is a “dividend play. I'll put it in the don't-buy camp. We need a bug drug from Lilly and they don't have it." For Deckers Outdoor (NASDAQ: DECK), he mentioned, "I think in light of what others are doing, I...